Polycythaemia
Results
Phase 3
This trial looked at ruxolitinib (INC424) for people with polycythaemia vera who didn’t respond to standard treatment.
Recruitment start: 4 March 2011
Recruitment end: 8 January 2013
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Claire Harrison
Incyte Corporation
NIHR Clinical Research Network: Cancer
Novartis
Last reviewed: 27 Jun 2016
CRUK internal database number: 7694
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
